osimertinib
astrazeneca
['osimertinib']
 poster at #asco22 on mechanisms of resistance to osimertinib. squamous/neurowndocrine transformation in a significant number. 3.2% c797s, 10% met. only able to do because of #mskimpact 
Medical Oncologist at Memorial Sloan Kettering. Clinical focus on patients with lung & thymic cancers. COI: https://t.co/lXxGGb6HFw